Effect of Mulligan Mobilization With or Without Niel Asher Technique in Patients With Adhesive Capsulitis

NCT ID: NCT06985836

Last Updated: 2025-05-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

42 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-12-15

Study Completion Date

2025-06-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Adhesive capsulitis is a prevalent condition characterized by pain and stiffness in shoulder joint and surrounding muscles shows decrease range and strength in patients with adhesive capsulitis. This study aims to determine the effect of mulligan mobilization with or without Niel Asher technique on pain, range of motion and disability in patients with adhesive capsulitis. This study will be a randomized controlled trial and will be conducted in Ibne-siena Hospital Multan and Multicare physiotherapy clinic. Non-probability convenience sampling will be used to collect the data. Sample size of subjects with age group between 40 to 60 years will be taken. Data will be collected from the patients having present complaint of adhesive capsulitis. Outcome measures used will be Numeric pain rating scale (NPRS) for shoulder pain and SPADI for shoulder disability and Universal Goniometer (GU) for Range of motion. An informed consent will be taken. Subjects will be selected on the basis of inclusion and exclusion criteria. Subjects will be divided into two groups by random number generator table. Both the Groups will receive heating pad, TENS. Group A will receive Mulligan Mobilizations and Neil Asher technique, and Group B will receive Mulligan mobilization and Conventional Treatment. Outcome measures will be measured at baseline and after 4 weeks. Data analysis will be done by SPSS version 26.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Adhesive Capsulitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Mulligan Mobilization and Niel Asher technique

Shoulder mobilization that includes:

* Mulligan mobilization technique for shoulder external rotation and abduction as described by Mulligan. 3 sets of 10 repetitions with 1 minute rest between sets, 3 times a week for 4 weeks are performed
* Niel Asher technique provided for 3 sessions a week for 4 weeks

Group Type EXPERIMENTAL

Mulligan Mobilization and Niel Asher technique

Intervention Type OTHER

* Mulligan mobilization technique for shoulder external rotation and abduction as described by Mulligan. 3 sets of 10 repetitions with 1 minute rest between sets, 3 times a week for 4 weeks are performed
* Niel Asher technique provided for 3 sessions a week for 4 weeks

Mulligan Mobilization and Conventional physiotherapy.

Intervention Type OTHER

* Modalities i.e. heating pad and TENS for ten Minutes
* Postural correction exercises / Scapular retraction
* Therapeutic Exercise : Codman' s, finger ladder, wand exercises
* End Range Gleno-humeral joint stretching Both groups will come four times per week for a total of 4 weeks. Pre and post treatment values of both groups will be analyzed.

Mulligan Mobilization and Conventional physiotherapy.

Group B Will receive Baseline Physical therapy treatment and mulligan mobilization.

Standardized Physiotherapy treatment will be:

* Modalities i.e. heating pad and TENS for ten Minutes
* Postural correction exercises / Scapular retraction
* Therapeutic Exercise : Codman' s, finger ladder, wand exercises
* End Range Gleno-humeral joint stretching Both groups will come four times per week for a total of 4 weeks. Pre and post treatment values of both groups will be analyzed

Group Type ACTIVE_COMPARATOR

Mulligan Mobilization and Conventional physiotherapy.

Intervention Type OTHER

* Modalities i.e. heating pad and TENS for ten Minutes
* Postural correction exercises / Scapular retraction
* Therapeutic Exercise : Codman' s, finger ladder, wand exercises
* End Range Gleno-humeral joint stretching Both groups will come four times per week for a total of 4 weeks. Pre and post treatment values of both groups will be analyzed.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mulligan Mobilization and Niel Asher technique

* Mulligan mobilization technique for shoulder external rotation and abduction as described by Mulligan. 3 sets of 10 repetitions with 1 minute rest between sets, 3 times a week for 4 weeks are performed
* Niel Asher technique provided for 3 sessions a week for 4 weeks

Intervention Type OTHER

Mulligan Mobilization and Conventional physiotherapy.

* Modalities i.e. heating pad and TENS for ten Minutes
* Postural correction exercises / Scapular retraction
* Therapeutic Exercise : Codman' s, finger ladder, wand exercises
* End Range Gleno-humeral joint stretching Both groups will come four times per week for a total of 4 weeks. Pre and post treatment values of both groups will be analyzed.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age group 40-60 year
* Both gender male and female
* Stage 2 primary adhesive capsulitis with capsular pattern of restriction (rotation\>abduction\>flexion)
* Pain in shoulder should be ≤7 on NPRS
* Patient is willing to perform.

Exclusion Criteria

* • Diabetes

* Malignancy
* Infection
* Arthoplasty
* Pregnancy
* Neurological disorders
* Fracture
* Thyroid diseases
Minimum Eligible Age

40 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Riphah International University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Rabiya Noor, PHD

Role: PRINCIPAL_INVESTIGATOR

Riphah International University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ibne Siena hospital Multan.

Multan Khurd, Punjab Province, Pakistan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Iqbal Tariq, PHD

Role: CONTACT

03338236752

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Iqra Fatima, MSOMPT

Role: primary

Rabiya Noor, PHD

Role: backup

03344355660

References

Explore related publications, articles, or registry entries linked to this study.

Doner G, Guven Z, Atalay A, Celiker R. Evalution of Mulligan's technique for adhesive capsulitis of the shoulder. J Rehabil Med. 2013 Jan;45(1):87-91. doi: 10.2340/16501977-1064.

Reference Type BACKGROUND
PMID: 23037929 (View on PubMed)

Childs JD, Piva SR, Fritz JM. Responsiveness of the numeric pain rating scale in patients with low back pain. Spine (Phila Pa 1976). 2005 Jun 1;30(11):1331-4. doi: 10.1097/01.brs.0000164099.92112.29.

Reference Type BACKGROUND
PMID: 15928561 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

REC/RCR & AHS/24/0180

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.